Enanta Pharmaceuticals Inc (NAS:ENTA) Stock News, Headlines & Updates
Enanta Pharmaceuticals Inc Stock News from GuruFocus
- 1
Jul 15, 2025
Enanta Pharmaceuticals to Participate in Baird's Biotech Discovery Series
Business Wire • 7:00am
Enanta Pharmaceuticals to Participate in Baird's Biotech Discovery Series | ENTA Stock News
GuruFocus News • 6:21am
Jun 11, 2025
Enanta Pharmaceuticals' Partner AbbVie Receives U.S. FDA Approval of an Expanded Indication for MAVYRET® (glecaprevir/pibrentasvir) as the First and Only Treatment for People with Acute Hepatitis C Vi
GuruFocus News • 11:45am
Jun 03, 2025
Enanta Pharma (ENTA) Receives Target Price Boost from JMP Securities | ENTA Stock News
GuruFocus News • 10:00am
Enanta (ENTA) Price Target Raised as Key Clinical Results Anticipated | ENTA Stock News
GuruFocus News • 5:00am
May 27, 2025
Enanta Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
Business Wire • 7:00am
Enanta Pharmaceuticals to Present at the Jefferies Global Healthcare Conference | ENTA Stock News
GuruFocus News • 6:21am
May 22, 2025
Enanta Pharmaceuticals Announces Data from its Phase 2 Study of Zelicapavir in Children with Respiratory Syncytial Virus to be Presented at the 43rd Annual ESPID Meeting
Business Wire • 7:00am
May 14, 2025
Citizens JMP Increases Enanta (ENTA) Price Target to $23 | ENTA Stock News
GuruFocus News • 5:16am
May 12, 2025
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2025
Business Wire • 4:00pm
Enanta (ENTA) Reports Revenue Miss and Advances Drug Development Programs | ENTA Stock News
GuruFocus News • 3:53pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news